CAMBRIDGE, Mass., June 15 /PRNewswire-FirstCall/ -- Javelin Pharmaceuticals, Inc. (OTC Bulletin Board: JVPH - News), a developer of innovative pain medications, today announced that Martin Driscoll and Neil Flanzraich have been elected to its Board of Directors.
